NextCure, Inc. 8-K

What Happened
NextCure, Inc. (NXTC) filed a Form 8-K on May 7, 2026 (Item 2.02) furnishing a press release that announces the company's financial results for the quarter ended March 31, 2026. The press release is attached to the filing as Exhibit 99.1; the filing also includes the cover page interactive data file (inline XBRL) as Exhibit 104.

Key Details

• Filing date: May 7, 2026 (Form 8-K, Item 2.02 and Item 9.01).
• Reporting period: quarter ended March 31, 2026.
• Exhibit: Press release attached as Exhibit 99.1.
• Technical exhibit: Cover Page Interactive Data File (Inline XBRL) provided as Exhibit 104.

Why It Matters
This 8-K signals that NextCure has publicly released its latest quarterly earnings information; investors should read the attached press release for the actual earnings, revenue, cash position, and management commentary. Because the Form 8-K furnishes the press release rather than amending other filings, any material figures or forward-looking statements will be found in Exhibit 99.1 and may be followed by subsequent SEC filings or investor materials. Review the press release and subsequent SEC disclosures to assess impacts on revenue, guidance, liquidity, or valuation.